Details for New Drug Application (NDA): 020044
✉ Email this page to a colleague
The generic ingredient in EXOSURF NEONATAL is cetyl alcohol; colfosceril palmitate; tyloxapol. There are ninety-one drug master file entries for this compound. Additional details are available on the cetyl alcohol; colfosceril palmitate; tyloxapol profile page.
Summary for 020044
Tradename: | EXOSURF NEONATAL |
Applicant: | Glaxosmithkline |
Ingredient: | cetyl alcohol; colfosceril palmitate; tyloxapol |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SUSPENSION;INTRATRACHEAL | Strength | 12MG/VIAL;108MG/VIAL;8MG/VIAL | ||||
Approval Date: | Aug 2, 1990 | TE: | RLD: | No |
Expired US Patents for NDA 020044
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxosmithkline | EXOSURF NEONATAL | cetyl alcohol; colfosceril palmitate; tyloxapol | FOR SUSPENSION;INTRATRACHEAL | 020044-001 | Aug 2, 1990 | 4,312,860 | ⤷ Subscribe |
Glaxosmithkline | EXOSURF NEONATAL | cetyl alcohol; colfosceril palmitate; tyloxapol | FOR SUSPENSION;INTRATRACHEAL | 020044-001 | Aug 2, 1990 | 5,110,806 | ⤷ Subscribe |
Glaxosmithkline | EXOSURF NEONATAL | cetyl alcohol; colfosceril palmitate; tyloxapol | FOR SUSPENSION;INTRATRACHEAL | 020044-001 | Aug 2, 1990 | 4,826,821 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription